NCT02512939View on ClinicalTrials.gov

Predictive Values of Next Generation Interferon Gamma Release Assays for Latent Tuberculosis Infection

NACompletedINTERVENTIONAL
Enrollment

675

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions
Tuberculosis
Interventions
PROCEDURE

blood test, not yet marketed, no trade name

blood test using the new TB diagnostic test

Trial Locations (5)

Unknown

Barts NHS Trust, London

Ealing Hospital, London

North Middlesex Hospital, London

Northwick Park Hospital, London

West Middlesex Hospital NHS Trust, London

All Listed Sponsors
collaborator

Public Health England

OTHER_GOV

lead

University College, London

OTHER

NCT02512939 - Predictive Values of Next Generation Interferon Gamma Release Assays for Latent Tuberculosis Infection | Biotech Hunter | Biotech Hunter